SANDSTONE Asset Management 13D and 13G filings for Carmell Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-18 3:03 pm Purchase | 2024-04-04 | 13G | Carmell Therapeutics Corporation CTCX | SANDSTONE Asset Management | 1,017,615 4.945% | 1,017,615 (New Position) | Filing |